Učitavanje...
Dexamethasone in hyperleukocytic acute myeloid leukemia
Patients with acute myeloid leukemia and a high white blood cell count are at increased risk of early death and relapse. Because mediators of inflammation contribute to leukostasis and chemoresistance, dexamethasone added to chemotherapy could improve outcomes. This retrospective study evaluated the...
Spremljeno u:
| Izdano u: | Haematologica |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Ferrata Storti Foundation
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6058767/ https://ncbi.nlm.nih.gov/pubmed/29519869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.184267 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|